Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment.
Identifieur interne : 000708 ( Main/Exploration ); précédent : 000707; suivant : 000709Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment.
Auteurs : Young Ho Lee [Corée du Sud]Source :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2019.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
DOI: 10.1136/annrheumdis-2018-214635
PubMed: 30389689
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000615
- to stream PubMed, to step Curation: 000615
- to stream PubMed, to step Checkpoint: 000279
- to stream Ncbi, to step Merge: 001C64
- to stream Ncbi, to step Curation: 001C64
- to stream Ncbi, to step Checkpoint: 001C64
- to stream Main, to step Merge: 000708
- to stream Main, to step Curation: 000708
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment.</title><author><name sortKey="Lee, Young Ho" sort="Lee, Young Ho" uniqKey="Lee Y" first="Young Ho" last="Lee">Young Ho Lee</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Korea University Medical Center, Seoul 02841, South Korea lyhcgh@korea.ac.kr.</nlm:affiliation><country wicri:rule="url">Corée du Sud</country><wicri:regionArea>Division of Rheumatology, Korea University Medical Center, Seoul 02841</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:30389689</idno><idno type="pmid">30389689</idno><idno type="doi">10.1136/annrheumdis-2018-214635</idno><idno type="wicri:Area/PubMed/Corpus">000615</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000615</idno><idno type="wicri:Area/PubMed/Curation">000615</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000615</idno><idno type="wicri:Area/PubMed/Checkpoint">000279</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000279</idno><idno type="wicri:Area/Ncbi/Merge">001C64</idno><idno type="wicri:Area/Ncbi/Curation">001C64</idno><idno type="wicri:Area/Ncbi/Checkpoint">001C64</idno><idno type="wicri:Area/Main/Merge">000708</idno><idno type="wicri:Area/Main/Curation">000708</idno><idno type="wicri:Area/Main/Exploration">000708</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment.</title><author><name sortKey="Lee, Young Ho" sort="Lee, Young Ho" uniqKey="Lee Y" first="Young Ho" last="Lee">Young Ho Lee</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Korea University Medical Center, Seoul 02841, South Korea lyhcgh@korea.ac.kr.</nlm:affiliation><country wicri:rule="url">Corée du Sud</country><wicri:regionArea>Division of Rheumatology, Korea University Medical Center, Seoul 02841</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author></analytic><series><title level="j">Annals of the rheumatic diseases</title><idno type="eISSN">1468-2060</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antibodies, Monoclonal, Humanized</term><term>Double-Blind Method</term><term>Glucocorticoids</term><term>Humans</term><term>Still's Disease, Adult-Onset</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Anticorps monoclonaux humanisés</term><term>Glucocorticoïdes</term><term>Humains</term><term>Maladie de Still débutant à l'âge adulte</term><term>Méthode en double aveugle</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term><term>Glucocorticoids</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Double-Blind Method</term><term>Humans</term><term>Still's Disease, Adult-Onset</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Anticorps monoclonaux humanisés</term><term>Glucocorticoïdes</term><term>Humains</term><term>Maladie de Still débutant à l'âge adulte</term><term>Méthode en double aveugle</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>Corée du Sud</li></country><region><li>Région capitale de Séoul</li></region><settlement><li>Séoul</li></settlement></list><tree><country name="Corée du Sud"><region name="Région capitale de Séoul"><name sortKey="Lee, Young Ho" sort="Lee, Young Ho" uniqKey="Lee Y" first="Young Ho" last="Lee">Young Ho Lee</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000708 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000708 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30389689
|texte= Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30389689" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a TocilizumabV1
| This area was generated with Dilib version V0.6.34. |  |